The pharmaceutical industry has had a rough go of it lately. Between negative headlines (with the recent Mylan EpiPen controversy only the latest controversy), congressional inquiries and calls from insurers and the medical community to defend the price of medications, today's value-focused healthcare landscape presents an unprecedented set of challenges for the sector.
Do you have info to share with HuffPost reporters? Here’s how.
In an age where we talk incessantly about the virtues of equality, local empowerment, engagement, freedom of choice, small business and democracy, the forces of monopoly seem to be gaining ground, sowing elitist seeds that make society's relationships more volatile. Surely none of us play a role in all of this - or do we?